240 related articles for article (PubMed ID: 31099380)
1. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
Mordue DG; Wormser GP
J Infect Dis; 2019 Jul; 220(3):442-447. PubMed ID: 31099380
[TBL] [Abstract][Full Text] [Related]
2. Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo.
Carvalho LJM; Tuvshintulga B; Nugraha AB; Sivakumar T; Yokoyama N
Parasit Vectors; 2020 Jul; 13(1):362. PubMed ID: 32690081
[TBL] [Abstract][Full Text] [Related]
3. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the Antimalarial MMV390048 against
Ji S; Galon EM; Rizk MA; Yi Y; Zafar I; Li H; Ma Z; Iguchi A; Asada M; Liu M; Xuan X
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0057422. PubMed ID: 35924942
[TBL] [Abstract][Full Text] [Related]
5. Plasma Blood Levels of Tafenoquine following a Single Oral Dosage in BALBc Mice with Acute
Mordue DG; Hale SJ; Dennis WE; Vuong CV; Li XM; Yang N; Wormser GP
Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764921
[TBL] [Abstract][Full Text] [Related]
6. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
7. Tafenoquine Is a Promising Drug Candidate for the Treatment of Babesiosis.
Liu M; Ji S; Kondoh D; Galon EM; Li J; Tomihari M; Yanagawa M; Tagawa M; Adachi M; Asada M; Igarashi I; Iguchi A; Xuan X
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0020421. PubMed ID: 33941516
[TBL] [Abstract][Full Text] [Related]
8. HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes.
Schwake C; Baldwin MR; Bachovchin W; Hegde S; Schiemer J; Okure C; Levin AE; Vannier E; Hanada T; Chishti AH
Biochem Biophys Res Commun; 2019 Sep; 517(1):125-131. PubMed ID: 31311649
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of the experimental animal model of Babesia microti].
Lu Y; Cai YC; Chen SH; Chen JX; Guo J; Chen MX; Ai L; Chu YH; Chen Z; Zhou XN
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Dec; 30(6):423-7. PubMed ID: 23484250
[TBL] [Abstract][Full Text] [Related]
10. Elimination of
Skariah S; Arnaboldi P; Dattwyler RJ; Sultan AA; Gaylets C; Walwyn O; Mulhall H; Wu X; Dargham SR; Mordue DG
J Immunol; 2017 Jul; 199(2):633-642. PubMed ID: 28607116
[TBL] [Abstract][Full Text] [Related]
11. Impact of Babesia microti infection on the initiation and course of pregnancy in BALB/c mice.
Tołkacz K; Rodo A; Wdowiarska A; Bajer A; Bednarska M
Parasit Vectors; 2021 Mar; 14(1):132. PubMed ID: 33653384
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Plasmodium cynomolgi in rhesus macaques by coinfection with Babesia microti.
van Duivenvoorde LM; Voorberg-van der Wel A; van der Werff NM; Braskamp G; Remarque EJ; Kondova I; Kocken CH; Thomas AW
Infect Immun; 2010 Mar; 78(3):1032-9. PubMed ID: 20048045
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of inhibitory effect of redox-active antimalarial drug against Babesia microti in mice.
Szymczak J; Kozłowska J; Doligalska M
Ann Parasitol; 2017; 63(3):223–227. PubMed ID: 29274217
[TBL] [Abstract][Full Text] [Related]
14. Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo.
Nehrbass-Stuedli A; Boykin D; Tidwell RR; Brun R
Antimicrob Agents Chemother; 2011 Jul; 55(7):3439-45. PubMed ID: 21537025
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of 19 antiprotozoal drugs and antibiotics on Babesia microti infection in BALB/c mice.
Yao JM; Zhang HB; Liu CS; Tao Y; Yin M
J Infect Dev Ctries; 2015 Sep; 9(9):1004-10. PubMed ID: 26409742
[TBL] [Abstract][Full Text] [Related]
16. Babesia microti infection, eastern Pennsylvania, USA.
Acosta ME; Ender PT; Smith EM; Jahre JA
Emerg Infect Dis; 2013 Jul; 19(7):1105-7. PubMed ID: 23764008
[TBL] [Abstract][Full Text] [Related]
17. The impact of ABO and RhD blood types on Babesia microti infection.
Jajosky RP; O'Bryan J; Spichler-Moffarah A; Jajosky PG; Krause PJ; Tonnetti L
PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011060. PubMed ID: 36696414
[TBL] [Abstract][Full Text] [Related]
18. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
19. Tafenoquine-Atovaquone Combination Achieves Radical Cure and Confers Sterile Immunity in Experimental Models of Human Babesiosis.
Vydyam P; Pal AC; Renard I; Chand M; Kumari V; Gennaro JC; Mamoun CB
J Infect Dis; 2024 Jan; 229(1):161-172. PubMed ID: 38169301
[TBL] [Abstract][Full Text] [Related]
20. Screening for biomarkers reflecting the progression of Babesia microti infection.
Xu B; Liu XF; Cai YC; Huang JL; Zhang RX; Chen JH; Cheng XJ; Zhou X; Xu XN; Zhou Y; Zhang T; Chen SB; Li J; Wu QF; Sun CS; Fu YF; Chen JX; Zhou XN; Hu W
Parasit Vectors; 2018 Jul; 11(1):379. PubMed ID: 29970143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
